Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Akil A Merchant

Showing results (21-30 of 26) with videos related to

Pageof 3
Sort By:
You have reached the last page of results.This site can display upto 26 results.
The Lancet. Haematology|July 9, 2017
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE studyHagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, et al.
Stem Cells (Dayton, Ohio)|December 24, 2005
Differential mRNA processing in hematopoietic stem cellsTeresa V Bowman, Andrew J McCooey, Akil A Merchant, et al.
Iscience|September 17, 2024
Low booster uptake in cancer patients despite health benefitsJane C Figueiredo, Julia Levy, So Yung Choi, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Low booster uptake in cancer patients despite health benefitsJane C Figueiredo, Julia Levy, So Yung Choi, et al.
Blood Advances|December 5, 2025
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosisXue Kong, Zijun Y Xu-Monette, Zhenming Xu, et al.
Clinical Lung Cancer|August 9, 2024
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 InfectionsMedha Somisetty, Philip C Mack, Chih-Yuan Hsu, et al.
Pageof 3

Showing results (21-30 of 26) with videos related to

Sort By:
Pageof 3
You have reached the last page of results.This site can display upto 26 results.
The Lancet. Haematology|July 9, 2017
Hepatic adverse event profile of inotuzumab ozogamicin in adult patients with relapsed or refractory acute lymphoblastic leukaemia: results from the open-label, randomised, phase 3 INO-VATE studyHagop M Kantarjian, Daniel J DeAngelo, Anjali S Advani, et al.
Stem Cells (Dayton, Ohio)|December 24, 2005
Differential mRNA processing in hematopoietic stem cellsTeresa V Bowman, Andrew J McCooey, Akil A Merchant, et al.
Iscience|September 17, 2024
Low booster uptake in cancer patients despite health benefitsJane C Figueiredo, Julia Levy, So Yung Choi, et al.
Medrxiv : the Preprint Server for Health Sciences|November 14, 2023
Low booster uptake in cancer patients despite health benefitsJane C Figueiredo, Julia Levy, So Yung Choi, et al.
Blood Advances|December 5, 2025
Proinflammatory GSDMD activation in live macrophages and DLBCL cells marks cognate interactions and better prognosisXue Kong, Zijun Y Xu-Monette, Zhenming Xu, et al.
Clinical Lung Cancer|August 9, 2024
Characteristics of Lung Cancer Patients With Asymptomatic or Undiagnosed SARS-CoV-2 InfectionsMedha Somisetty, Philip C Mack, Chih-Yuan Hsu, et al.
Pageof 3